Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Anhui Anke Biotechnology (Group) Co Ltd Announces FY 2013 Q1-Q3 Net Profit Outlook


Monday, 14 Oct 2013 08:00pm EDT 

Anhui Anke Biotechnology (Group) Co Ltd announced that it expects the net profit for the first three quarters of fiscal year 2013 to be RMB 64 million to RMB 67 million, or to increase by 24% to 30%, compared to that of fiscal year 2012 (RMB 51.61 million). The Company cited the increasing growth of its main business as well as the controlled cost as the main reasons for this forecast. 

Company Quote